Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Insight Partners | PRODUCT CODE: 1118996

Cover Image

PUBLISHER: The Insight Partners | PRODUCT CODE: 1118996

Europe Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product, Technology, Method, Test Type, Pathogen, and End User

PUBLISHED:
PAGES: 198 Pages
DELIVERY TIME: 1-5 business days
SELECT AN OPTION
PDF (Single User License)
USD 3000
PDF (Site License)
USD 4000
PDF (Enterprise License)
USD 5000

Add to Cart

The Europe sepsis diagnostics market is expected to grow from US$ 193.12 million in 2021 to US$ 360.55 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2021 to 2028.

Technology is a critical parameter in healthcare diagnostics to provide accuracy and save time and resources. In the sepsis diagnosis process, identifying the causative pathogen is essential in selecting appropriate antibiotic therapy as part of the treatment. Molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology are majorly used sepsis diagnostics techniques. Among all, molecular diagnostics (MDx) is an attractive approach to consider for sepsis diagnostics. The increasing adoption of molecular diagnostic technology due to its several advantages, such as high sensitivity, accuracy, and less turnaround time, over other technologies has proved it the gold standard. Therefore, several companies are investing in point-of-care molecular diagnostics to diagnose bacterial and viral pathogens early and for better patient management.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe sepsis diagnostics market. The Europe sepsis diagnostics market is expected to grow at a good CAGR during the forecast period.

Europe Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million )

Europe Sepsis Diagnostics Market Segmentation

The Europe sepsis diagnostics market is segmented based on product, technology, method, test type, pathogen, end user, and country. Based on product, the Europe sepsis diagnostics market is divided into instruments, reagents and assays, blood culture media, and software. The blood culture media dominated the Europe sepsis diagnostics market in 2021. Based on technology, the Europe sepsis diagnostics market is categorized into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment dominated the Europe sepsis diagnostics market in 2021. Based on method, the Europe sepsis diagnostics market is categorized into automated diagnostics and conventional diagnostics. The conventional diagnostics segment dominated the Europe sepsis diagnostics market in 2021. Based on test type, the Europe sepsis diagnostics market is categorized into point-of-care tests and laboratory tests. The laboratory tests segment dominated the Europe sepsis diagnostics market in 2021. Based on pathogen, the Europe sepsis diagnostics market is categorized into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment dominated the Europe sepsis diagnostics market in 2021. Based on end user, the Europe sepsis diagnostics market is categorized into hospitals, pathology and reference laboratories, and others. The hospitals segment dominated the Europe sepsis diagnostics market in 2021. Based on country, the Europe sepsis diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe sepsis diagnostics market in 2021.

Key players operating in the Europe sepsis diagnostics market include Abbott; F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; BD; Danaher (Beckman Coulter); Luminex Corporation; THERMO FISHER SCIENTIFIC INC.; bioMerieux SA; T2 Biosystems, Inc.; and Axis-Shield Diagnostics Ltd by Altair.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe sepsis diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe sepsis diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Product Code: BMIRE00025660

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Sepsis Diagnostics Market - By Product
    • 1.3.2 Europe Sepsis Diagnostics Market - By Technology
    • 1.3.3 Europe Sepsis Diagnostics Market - By Method
    • 1.3.4 Europe Sepsis Diagnostics Market - By Test Type
    • 1.3.5 Europe Sepsis Diagnostics Market - By Pathogen
    • 1.3.6 Europe Sepsis Diagnostics Market - By End User
    • 1.3.7 Europe Sepsis Diagnostics Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Sepsis Diagnostics Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Europe PEST Analysis
  • 4.3 Experts Opinion

5. Europe Sepsis Diagnostics Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
    • 5.1.2 Increase in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
  • 5.2 Market Restraints
    • 5.2.1 Absence of Skilled Professionals
  • 5.3 Market Opportunities
    • 5.3.1 Rise in Funding and Support for Sepsis Diagnostics Research
  • 5.4 Future Trends
    • 5.4.1 Growing Technological Advancements in Sepsis Diagnosis
  • 5.5 Impact Analysis

6. Sepsis Diagnostics Market- Europe Analysis

  • 6.1 Europe Sepsis Diagnostics Market Revenue Forecast and Analysis

7. Europe Sepsis Diagnostics Market - By Product

  • 7.1 Overview
  • 7.2 Europe Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
  • 7.3 Instruments
    • 7.3.1 Overview
    • 7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.4 Reagents and Assays
    • 7.4.1 Overview
    • 7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.5 Blood Culture Media
    • 7.5.1 Overview
    • 7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • 7.6 Software
    • 7.6.1 Overview
    • 7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. Europe Sepsis Diagnostics Market - By Technology

  • 8.1 Overview
  • 8.2 Europe Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
  • 8.3 Molecular Diagnostics
    • 8.3.1 Overview
    • 8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.1 Polymerase Chain Reaction
        • 8.3.2.1.1 Overview
        • 8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
        • 8.3.2.2.1 Overview
        • 8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.3 Syndromic Panel-Based Testing
        • 8.3.2.3.1 Overview
        • 8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.4 Microarrays
        • 8.3.2.4.1 Overview
        • 8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Flow Cytometry
    • 8.4.1 Overview
    • 8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Microfluidics
    • 8.5.1 Overview
    • 8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Immunoassay
    • 8.6.1 Overview
    • 8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Biomarkers
    • 8.7.1 Overview
    • 8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 8.8 Microbiology
    • 8.8.1 Overview
    • 8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Sepsis Diagnostics Market - By Method

  • 9.1 Overview
  • 9.2 Europe Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
  • 9.3 Automated Diagnostics
    • 9.3.1 Overview
    • 9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Conventional Diagnostics
    • 9.4.1 Overview
    • 9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Sepsis Diagnostics Market - By Test Type

  • 10.1 Overview
  • 10.2 Europe Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
  • 10.3 Point-of-Care Tests
    • 10.3.1 Overview
    • 10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Laboratory Tests
    • 10.4.1 Overview
    • 10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11. Europe Sepsis Diagnostics Market - By Pathogen

  • 11.1 Overview
  • 11.2 Europe Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
  • 11.3 Bacterial Sepsis
    • 11.3.1 Overview
    • 11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 11.4 Fungal Sepsis
    • 11.4.1 Overview
    • 11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12. Europe Sepsis Diagnostics Market - By End User

  • 12.1 Overview
  • 12.2 Europe Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
  • 12.3 Hospitals
    • 12.3.1 Overview
    • 12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 12.4 Pathology and Reference Laboratories
    • 12.4.1 Overview
    • 12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  • 12.5 Others
    • 12.5.1 Overview
    • 12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13. Europe Sepsis Diagnostics Market - By Country Analysis

  • 13.1 Europe: Sepsis Diagnostics Market
    • 13.1.1 Overview
    • 13.1.2 Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
      • 13.1.2.1 Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.1.1 Overview
        • 13.1.2.1.2 Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.1.3 Germany: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.1.4 Germany: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.1.4.1 Germany: Sepsis Diagnostics Market, by Molecular diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.1.5 Germany: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.1.6 Germany: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.1.7 Germany: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.1.8 Germany: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.1.2.2 France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.2.1 Overview
        • 13.1.2.2.2 France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.2.3 France: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.2.4 France: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.2.4.1 France: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.2.5 France: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.2.6 France: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.2.7 France: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.2.8 France: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.1.2.3 UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.3.1 Overview
        • 13.1.2.3.2 UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.3.3 UK: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.3.4 UK: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.3.4.1 UK: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.3.5 UK: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.3.6 UK: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.3.7 UK: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.3.8 UK: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.1.2.4 Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.4.1 Overview
        • 13.1.2.4.2 Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.4.3 Italy: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.4.4 Italy: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.4.4.1 Italy: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.4.5 Italy: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.4.6 Italy: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.4.7 Italy: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.4.8 Italy: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.1.2.5 Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.5.1 Overview
        • 13.1.2.5.2 Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.5.3 Spain: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.5.4 Spain: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.5.4.1 Spain: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.5.5 Spain: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.5.6 Spain: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.5.7 Spain: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.5.8 Spain: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 13.1.2.6 Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.6.1 Overview
        • 13.1.2.6.2 Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.6.3 Rest of Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.6.4 Rest of Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.6.4.1 Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.6.5 Rest of Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.6.6 Rest of Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.6.7 Rest of Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.6.8 Rest of Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)

14. Sepsis Diagnostics Market-Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies in the Sepsis Diagnostics Market (%)
  • 14.3 Organic Developments
    • 14.3.1 Overview
  • 14.4 Inorganic Developments
    • 14.4.1 Overview

15. Company Profiles

  • 15.1 Abbott
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 F. HOFFMANN-LA ROCHE LTD.
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Immunexpress Inc.
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 BD
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 Danaher (Beckman Coulter)
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 Luminex Corporation
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 THERMO FISHER SCIENTIFIC INC.
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 bioMerieux SA
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 T2 Biosystems, Inc.
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 Axis-Shield Diagnostics Ltd
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms
Product Code: BMIRE00025660

List Of Tables

  • Table 1.             Germany: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 2.             Germany: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 3.             Germany: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 4.             Germany: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 5.             Germany: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 6.             Germany: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
  • Table 7.             Germany: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 8.             France: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 9.             France: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 10.          France: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 11.          France: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 12.          France: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 13.          France: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
  • Table 14.          France: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 15.          UK: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 16.          UK: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 17.          UK: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 18.          UK: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 19.          UK: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 20.          UK: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
  • Table 21.          UK: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 22.          Italy: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 23.          Italy: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 24.          Italy: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 25.          Italy: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 26.          Italy: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 27.          Italy: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
  • Table 28.          Italy: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 29.          Spain: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 30.          Spain: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 31.          Spain: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 32.          Spain: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 33.          Spain: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 34.          Spain: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
  • Table 35.          Spain: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 36.          Rest of Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 37.          Rest of Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  • Table 38.          Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
  • Table 39.          Rest of Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  • Table 40.          Rest of Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 41.          Rest of Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
  • Table 42.          Rest of Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 43.          Organic Developments in the Sepsis Diagnostics Market
  • Table 44.          Inorganic Developments in the Sepsis Diagnostics Market
  • Table 45.          Glossary of Terms

List Of Figures

  • Figure 1.           Europe Sepsis Diagnostics Market Segmentation
  • Figure 2.           Europe Sepsis Diagnostics Market, By Country
  • Figure 3.           Europe Sepsis Diagnostics Market Overview
  • Figure 4.           Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market
  • Figure 5.           Germany is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6.           Europe: PEST Analysis
  • Figure 7.           Europe Experts Opinion
  • Figure 8.           Europe Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
  • Figure 9.           Europe Sepsis Diagnostics Market- Revenue Forecast and Analysis - 2021- 2028
  • Figure 10.        Europe Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
  • Figure 11.        Europe Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 12.        Europe Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 13.        Europe Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 14.        Europe Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 15.        Europe Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
  • Figure 16.        Europe Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 17.        Europe Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 18.        Europe Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 19.        Europe Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 20.        Europe Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 21.        Europe Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 22.        Europe Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 23.        Europe Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 24.        Europe Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 25.        Europe Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 26.        Europe Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
  • Figure 27.        Europe Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 28.        Europe Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 29.        Europe Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
  • Figure 30.        Europe Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 31.        Europe Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 32.        Europe Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
  • Figure 33.        Europe Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 34.        Europe Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 35.        Europe Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 36.        Europe Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
  • Figure 37.        Europe Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 38.        Europe Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 39.        Europe Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 40.        Europe: Sepsis Diagnostics Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 41.        Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
  • Figure 42.        Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43.        France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44.        UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45.        Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46.        Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47.        Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48.        Growth Strategies in the Sepsis Diagnostics Market (%)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!